Evidence map›Paper›PMID 40145287›Full record

ArticleJournal of the American Heart Association2025

Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models.

Sulaiman Somani, Dale Daniel Kim, Eduardo Perez-Guerrero, Summer Ngo, Tina Seto, Sadeer Al-Kindi, Tina Hernandez-Boussard, Fatima Rodriguez

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Harnessing Large Language Models for Chart Review.Journal of the American Heart Association · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sulaiman SomaniDepartment of Medicine Stanford University Stanford CA USA.ORCID 0000-0003-0913-8674
Dale Daniel KimSchool of Medicine Stanford University Stanford CA USA.ORCID 0000-0003-1987-3680
Eduardo Perez-GuerreroDepartment of Medicine Stanford University Stanford CA USA.ORCID 0009-0006-1899-7074
Summer NgoDivision of Cardiovascular Medicine, Cardiovascular Institute, and the Center for Digital Health Stanford University Stanford CA USA.ORCID 0000-0002-7434-4143
Tina SetoTechnology and Digital Solutions Stanford Health Care Stanford CA USA.ORCID 0000-0002-7937-9564
Sadeer Al-KindiDeBakey Heart and Vascular Center Houston Methodist Houston TX USA.ORCID 0000-0002-1122-7695
Tina Hernandez-BoussardDepartment of Biomedical Data Science Stanford University Stanford CA USA.ORCID 0000-0001-6553-3455
Fatima RodriguezDivision of Cardiovascular Medicine, Cardiovascular Institute, and the Center for Digital Health Stanford University Stanford CA USA.ORCID 0000-0002-5226-0723

Funding

Opportunistic Atherosclerotic Cardiovascular Disease Risk Estimation at Abdominal CTs with Robust and Unbiased Deep LearningR01HL167974 · NHLBI · STANFORD UNIVERSITY · PI Imon Banerjee, Akshay Chaudhari · 2023 to 2026
$2.4M
Novel Incidental Calcium Evaluation (NICE)R01HL169345 · NHLBI · STANFORD UNIVERSITY · PI Imon Banerjee, Akshay Chaudhari · 2024 to 2026
$2.1M
Adherence Determinants in the Health Electronic Record Evaluation of Statins (ADHERES)R01HL168188 · NHLBI · STANFORD UNIVERSITY · PI Fatima Rodriguez · 2024 to 2026
$2.1M
NHLBI NIH HHS R01 HL167974NHLBI NIH HHS R01 HL168188NHLBI NIH HHS R01 HL169345
6 · The paper itself

Abstract

backgroundRates of oral anticoagulation (OAC) nonprescription in atrial fibrillation approach 50%. Understanding reasons for OAC nonprescription may reduce gaps in guideline-recommended care. We aimed to identify reasons for OAC nonprescription from clinical notes using large language models.

methodsWe identified all patients and associated clinical notes in our health care system with a clinician-billed visit for atrial fibrillation without another indication for OAC and stratified them on the basis of active OAC prescriptions. Three annotators labeled reasons for OAC nonprescription in clinical notes on 10% of all patients ("annotation set"). We engineered prompts for a generative large language model (Generative Pre-trained Transformer 4) and trained a discriminative large language model (ClinicalBERT) to identify reasons for OAC nonprescription and selected the best-performing model to predict reasons for the remaining 90% of patients ("inference set").

resultsA total of 35 737 patients were identified, of which 7712 (21.6%) did not have active OAC prescriptions. A total of 910 notes across 771 patients were annotated. Generative Pre-trained Transformer 4 outperformed ClinicalBERT (macro-F1 score across all reasons of 0.79, compared with 0.69 for ClinicalBERT). Using Generative Pre-trained Transformer 4 on the inference set, 61.1% of notes had documented reasons for OAC nonprescription, most commonly the alternative use of an antiplatelet agent (23.3%), therapeutic inertia (21.0%), and low burden of atrial fibrillation (17.1%).

conclusionsThis is the first study using large language models to extract documented reasons for OAC nonprescription from clinical notes in patients with atrial fibrillation and reveals guideline-discordant practices and actionable insights for the development of health system interventions to reduce OAC nonprescription.

Indexed as

AnticoagulantsAtrial FibrillationNonprescription DrugsStrokeAdministration, OralAgedAged, 80 and overElectronic Health RecordsFemaleHumansLarge Language ModelsMaleMiddle AgedRetrospective StudiesAnticoagulantsNonprescription Drugsatrial fibrillationelectronic health recordlarge language modelsoral anticoagulationstroke

Identifiers

PMID40145287
PMCPMC12132827

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.